✨ Your Portfolio is fetched and updated from zerodha.
Mid Pharmaceuticals
Market Cap
₹39,188 Cr.
P/E
48.72
  • Biocon
  • Concord Biotech
  • Advanced Enzyme
  • TJI Pharma
FAQs on Biocon Ltd. Shareprice

Biocon has given lower returns compared to its competitors.
Biocon has grown at ~19.83% over the last 1yrs while peers have grown at a median rate of 26.22%

Biocon is not expensive.
Latest PE of Biocon is 50.13, while 3 year average PE is 57.0.
Also latest EV/EBITDA of Biocon is 18.29 while 3yr average is 21.45.

Growth Table
  • Biocon Ltd.
  • Concord Biotech
  • Advanced Enzyme
Balance Sheet
  • Biocon Ltd.
  • Concord Biotech
  • Advanced Enzyme
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Biocon Ltd.
  • Concord Biotech
  • Advanced Enzyme
Cash Flow
  • Biocon Ltd.
  • Concord Biotech
  • Advanced Enzyme
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Biocon Ltd.
  • Concord Biotech
  • Advanced Enzyme
Quarterly Results
  • Biocon Ltd.
  • Concord Biotech
  • Advanced Enzyme
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Biocon Ltd. Financials

Biocon balance sheet is weak and might have solvency issues

Yes, The debt of Biocon is increasing.
Latest debt of Biocon is ₹14,055 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹11,212 Crs.

Yes, profit is increasing.
The profit of Biocon is ₹1,196 Crs for TTM, ₹1,022 Crs for Mar 2024 and ₹463 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Biocon latest dividend payout ratio is 5.87% and 3yr average dividend payout ratio is 18.02%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech